Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The destrin pseudogene (ENSG00000258540), annotated as "destrin (actin depolymerizing factor) pseudogene," is a DNA segment related in sequence to the functional gene *destrin (DSTN)* but has accumulated disabling mutations (such as premature stop codons and frameshifts) that prevent it from encoding a functional protein product[1][2][4]. Pseudogenes typically result from duplication or retrotransposition of a functional gene followed by loss of regulatory capacity and/or coding potential[2][4]. The destrin pseudogene is not expressed as a functional protein and is not classified as a receptor, enzyme, transporter, or transcription factor. It is considered genomic “junk DNA,” and is generally not associated with disease or therapeutic intent[2][4]. The presence of pseudogenes can sometimes confound genetic studies due to sequence similarity with functional genes, but they are not active drug targets, do not serve established biological functions, and do not interact with drugs[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on destrin (actin depolymerizing factor) pseudogene.